Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Online |
| Język: | angielski |
| Wydane: |
Frontiers Media SA
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | 31949 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy: Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
- ECG Based Analysis of the Ventricular Repolarisation in the Human Heart
- Sudden arrhythmic death: From basic science to clinical practice
- Cardiac Electrophysiology and Catheter Ablation of Different Arrhythmias
- Journal of Arrhythmia
- Вестник аритмологии
- Optogenetics: An Emerging Approach in Cardiac Electrophysiology